http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102512382-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86f9fd708fb86712e0772b8311214e17 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
filingDate | 2011-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0433f9d00caf75e90f8af560ea35f098 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdcffe9cb34ee64c8aa08e69d2fe9ee8 |
publicationDate | 2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102512382-B |
titleOfInvention | Esomeprazole sodium pharmaceutical composition for injection |
abstract | The invention relates to a stable and safe Esomeprazole sodium pharmaceutical composition for injection and a preparation method thereof, and provides a pharmaceutical composition for treating gastroesophageal reflux disease, stomach burning heat sensation caused by non-erosive gastroesophageal reflux and erosive esophagitis; and the pharmaceutical composition for injection is preferably a freeze-drying powder injection. The Esomeprazole sodium pharmaceutical composition mainly comprises active components of Esomeprazole sodium, mannitol and sodium hydroxide. The Esomeprazole sodium pharmaceutical composition for injection obtained by the invention has stable pH value and low impurity content, so as to effectively increase treatment effect of the product, reduce cost and create more benefits. |
priorityDate | 2011-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.